This is a catalyst swing trade. ECTE is expecting an European approval decision on its diabetes medical device around April
13th. The chart looks ready for a strong move north. The key level to watch is 3.31 After testing the lower bollinger band
a few times and establishing a bottom, Friday's volume
confirms that the stock is ready to break the upper bollinger band
and exit the accumulation area.